Skip to main content

Table 2 Comparison of baseline clinical characteristics between NA and CTA groups in pancreatic head cancer

From: Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location

Characteristic

NA(%)

n = 24

CTA(%)

n = 38

NA vs CTA

p value

Age, mean(year)

65

60

0.038

 rang

45–81

36–74

 

Sex

 Male

13(54)

24(63)

 

 Female

11(46)

14(37)

0.482

Tumor diameter, mean(mm)

34.1

34.5

0.884

 range

20–57.5

17.5–80

 

T stage

 T2

3(13)

4(11)

 

 T3

14(58)

27(71)

 

 T4

7(29)

7(18)

0.532

N stage

 N0

12(50)

19(50)

 

 N1

12(50)

19(50)

1

Resection marging

   

 R0

24(100)

35(92)

 

 R1

0(0)

3(8)

0.422

histological type

 Dactal adenocarcinoma

22(92)

37(97)

 

 Intraductal papillary-mucinous tumor

1(4)

0(0)

 

 Mucoepidermoid carcinoma

0(0)

1(3)

 

 Neuroendocrine neoplasms

1(4)

0(0)

0.331

Resection type

 pancreatoduodenectomy

19(79)

35(92)

 

 distal pancreatectomy

0(0)

0(0)

 

 pancreatoduodenectomy & total pancreatectomy

4(17)

2(5)

 

 pancreatoduodenectomy & distal pancreatectomy

1(4)

1(3)

0.315

Type of recurrence

 Local only

7(29)

18(47)

 

 local & metastasis

17(71)

20(53)

0.155

Relapse-free time interval, mean(month)

7.9

8.7

0.644

 range

1.1–43.2

1.4–17.8

 
  1. Abbreviations: NA no adjuvant therapy, CTA adjuvant chemotherapy alone